Angelo Cambio

542 total citations
15 papers, 391 citations indexed

About

Angelo Cambio is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Angelo Cambio has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Angelo Cambio's work include Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Pelvic floor disorders treatments (3 papers). Angelo Cambio is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Pelvic floor disorders treatments (3 papers). Angelo Cambio collaborates with scholars based in United States. Angelo Cambio's co-authors include Christopher P. Evans, Primo N. Lara, Eric A. Kurzrock, Eric C. Nelson, Joy C. Yang, Karen Giselle Chee, Gurkamal Chatta, Chong-xian Pan, Thuan Nguyen and Dana K. Nanigian and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

Angelo Cambio

15 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Cambio United States 9 213 119 105 95 91 15 391
W.D. Dunsmuir United Kingdom 11 172 0.8× 107 0.9× 246 2.3× 159 1.7× 155 1.7× 18 581
J.L. Álvarez-Ossorio Spain 10 127 0.6× 175 1.5× 70 0.7× 136 1.4× 43 0.5× 34 419
Mazen A. Ghanem Egypt 11 140 0.7× 200 1.7× 103 1.0× 52 0.5× 37 0.4× 24 375
Trevor Dorkin United Kingdom 14 135 0.6× 194 1.6× 163 1.6× 133 1.4× 106 1.2× 24 459
D. Rosell Spain 12 225 1.1× 87 0.7× 34 0.3× 174 1.8× 53 0.6× 50 401
Thierry Dujardin Canada 13 269 1.3× 88 0.7× 29 0.3× 74 0.8× 47 0.5× 27 445
Tae Jin Kim South Korea 11 132 0.6× 45 0.4× 47 0.4× 110 1.2× 60 0.7× 30 345
Kiran Gollapudi United States 12 162 0.8× 79 0.7× 55 0.5× 141 1.5× 20 0.2× 23 433
G. Fromont France 12 209 1.0× 101 0.8× 119 1.1× 256 2.7× 42 0.5× 37 486
Shushang Chen China 9 211 1.0× 102 0.9× 156 1.5× 25 0.3× 93 1.0× 16 360

Countries citing papers authored by Angelo Cambio

Since Specialization
Citations

This map shows the geographic impact of Angelo Cambio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Cambio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Cambio more than expected).

Fields of papers citing papers by Angelo Cambio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Cambio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Cambio. The network helps show where Angelo Cambio may publish in the future.

Co-authorship network of co-authors of Angelo Cambio

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Cambio. A scholar is included among the top collaborators of Angelo Cambio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Cambio. Angelo Cambio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cambio, Angelo, et al.. (2022). Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities. Advances in Urology. 2022. 1–9. 2 indexed citations
2.
Mener, David J., et al.. (2009). The impact of HMG‐CoA reductase therapy on serum PSA. The Prostate. 70(6). 608–615. 23 indexed citations
3.
Mener, David J., et al.. (2009). THE IMPACT OF HMG-COA REDUCTASE THERAPY ON SERUM PSA LEVEL. The Journal of Urology. 181(4S). 803–803. 1 indexed citations
4.
Cambio, Angelo, Christopher P. Evans, & Eric A. Kurzrock. (2008). Non‐surgical management of multicystic dysplastic kidney. British Journal of Urology. 101(7). 804–808. 38 indexed citations
5.
Nanigian, Dana K., et al.. (2008). Development and Validation of the Fecal Incontinence and Constipation Quality of Life Measure in Children With Spina Bifida. The Journal of Urology. 180(4S). 1770–1773. 43 indexed citations
6.
Nelson, Eric C., Angelo Cambio, Joy C. Yang, Primo N. Lara, & Christopher P. Evans. (2007). Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation. Nature Clinical Practice Urology. 4(2). 82–94. 7 indexed citations
7.
Hellenthal, Nicholas J., et al.. (2007). Renal cell carcinoma metastatic to gallbladder: a survival advantage to simultaneous nephrectomy and cholecystectomy. International Urology and Nephrology. 39(2). 377–379. 10 indexed citations
8.
Chee, Karen Giselle, Jeff Longmate, David I. Quinn, et al.. (2007). The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial. Clinical Genitourinary Cancer. 5(7). 433–437. 73 indexed citations
9.
Cambio, Angelo, Lars M. Ellison, Karim Chamie, Ralph W. deVere White, & Christopher P. Evans. (2007). Cost-Benefit and Outcome Analysis: Effect of Prostate Biopsy Undergrading. Urology. 69(6). 1152–1156. 2 indexed citations
10.
Cambio, Angelo & Christopher P. Evans. (2007). Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). Therapeutics and Clinical Risk Management. 3(1). 181–196. 9 indexed citations
11.
Cambio, Angelo & Christopher P. Evans. (2006). Minimising Postoperative Incontinence Following Radical Prostatectomy: Considerations and Evidence. European Urology. 50(5). 903–913. 85 indexed citations
12.
Nelson, Eric C., et al.. (2006). Clinical implications of neuroendocrine differentiation in prostate cancer. Prostate Cancer and Prostatic Diseases. 10(1). 6–14. 75 indexed citations
13.
Chee, Karen Giselle, Angelo Cambio, & Primo N. Lara. (2005). Recent developments in advanced urothelial cancer. Current Opinion in Urology. 15(5). 342–349. 5 indexed citations
14.
Cambio, Angelo & Christopher P. Evans. (2005). Management approaches to small renal tumours. British Journal of Urology. 97(3). 456–460. 16 indexed citations
15.
Cambio, Angelo, et al.. (2005). Is the use of anything but MVAC justified in the evidence-based medicine era?. Current Opinion in Urology. 15(5). 312–314. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.D. Dunsmuir Breakdown of academic impact, for papers by J.L. Álvarez-Ossorio Breakdown of academic impact, for papers by Mazen A. Ghanem Breakdown of academic impact, for papers by Trevor Dorkin Breakdown of academic impact, for papers by D. Rosell Breakdown of academic impact, for papers by Thierry Dujardin Breakdown of academic impact, for papers by Tae Jin Kim Breakdown of academic impact, for papers by Kiran Gollapudi Breakdown of academic impact, for papers by G. Fromont Breakdown of academic impact, for papers by Shushang Chen
Rankless by CCL
2026